Notícias

The novel coronavirus disease, caused by severe acute respiratory coronavirus 2 (SARS-CoV-2), rapidly spreading around the world, poses a major...

ABIFINA congratula novo presidente da Academia Nacional de Farmácia. Entidade
participa da cerimônia de posse da ACFB/ANF, na qual...

ABIFINA participa da 4ª reunião ordinária de 2021 do Conselho Nacional de Combate
à Pirataria (CNCP), órgão colegiado do...

Coronavirus disease 19 (COVID-19) can have a severe presentation characterized by a dysregulated immune response requiring admission to the intensive...

Academia NC, criada pelo Grupo NC, ao qual pertence a EMS, maior laboratório
farmacêutico no Brasil, desenvolveu plataforma digital...

Robust evidenced treatment strategy for Coronavirus disease 2019 (COVID-19) has not been established yet. Early, targeted, comprehensive management approach can...

A Blau Farmacêutica, uma das principais indústrias farmacêuticas da América Latina,
elegeu duas novas conselheiras – Andrea Destri e...

A previous efficacy trial found benefit from inhaled budesonide for COVID-19 in patients not admitted to hospital, but effectiveness in...

Serological assays to detect antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) might contribute to confirming the suspected coronavirus...

The severity of coronavirus disease 2019 (COVID-19) ranges from mild to death, with high morbidity and mortality rates reported amongst...

Coronavirus disease 2019 (COVID-19) is today’s most serious epidemic disease threatening the human race. The initial therapeutic approach of SARS-CoV-2...

The safety profile of remdesivir, conditionally approved for COVID-19, was limited at its 2020 introduction. Adverse drug reactions (ADRs) for...